Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 2011

View Archived Issues

Pfizer describes identification of new drug for allergic rhinitis

VANTAGE 88 reveals activity of combination therapy for multiple myeloma

Biomarkers of kidney injury identified in patients with MM

Galectin Therapeutics reviews recent progress

AstraZeneca provides update on olaparib and TC-5214 programs

U.K. study uncovers new biomarker for bronchiolitis obliterans syndrome

Kissei presents new nonpurine adenosine A2A receptor antagonists

GSK begins phase IIa trial of GSK-2586881

DiaMedica's humanized MAb for type 2 diabetes shows improved binding affinity

Merck & Co. discloses new B-raf inhibitors

Novel GPR119 receptor agonists discovered in Japan

GlaxoSmithKline presents novel protein kinase inhibitors

New 11-beta-HSD1 inhibitors developed in Korea

Novel somatostatin sst5 receptor antagonists synthesized

ALS Therapy Development Institute collaborates with Biogen Idec and UCB

Topline phase III data presented on teriflunomide in MS

FDA issues update on Multaq review

Repligen completes acquisition

Clinuvel reports final data from phase III afamelanotide trial

Affibody and Nuclisome join forces to develop cancer therapeutics

TiGenix clear to begin phase I study of stem cell product

EMA validates MAA for single-tablet HIV-1 therapy

Galaczym obtains new orphan drug status

Salix Pharmaceuticals acquires Oceana Therapeutics

ImmunoGen and Lilly enter collaboration for antibody-based anticancer therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...